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replacing the current text-only labels with graphic warning labels. However, labels proposed by the Food 
and Drug Administration (FDA) were challenged in court by the tobacco companies, who argued 
successfully that the proposed labels needlessly encroached on their right to free speech, in part because 
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Methods—We used functional MRI to examine the effects of graphic warning labels' emotional salience 
on smokers' brain activity and cognition. Twenty-four smokers viewed a random sequence of blocks of 
graphic warning labels that have been rated high or low on an ‘emotional reaction’ scale in previous 
research. 
Results—We found that labels rated high on emotional reaction were better remembered, associated with 
reduction in the urge to smoke, and produced greater brain response in the amygdala, hippocampi, inferior 
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Conclusions—Recognition memory and craving are, respectively, correlates of effectiveness of addiction 
related public health communications and interventions, and amygdala activation facilitates the encoding 
of emotional memories. Thus, our results suggest that emotional reaction to graphic warning labels 
contributes to their public health impact and may be an integral part of the neural mechanisms underlying 
their effectiveness. Given the urgency of the debate about the constitutional risks and public health 
benefits of graphic warning labels, these preliminary findings warrant consideration while longitudinal 
clinical studies are underway 
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Abstract
Background—Warning labels on cigarette packages are an important venue for information
about the hazards of smoking. The 2009 US Family Smoking Prevention and Tobacco Control Act
mandated replacing the current text-only labels with graphic warning labels. However, labels
proposed by the Food and Drug Administration (FDA) were challenged in court by the tobacco
companies, who argued successfully that the proposed labels needlessly encroached on their right
to free speech, in part because they included images of high emotional salience that
indiscriminately frightened rather than informed consumers.
Methods—We used functional MRI to examine the effects of graphic warning labels' emotional
salience on smokers' brain activity and cognition. Twenty-four smokers viewed a random
sequence of blocks of graphic warning labels that have been rated high or low on an ‘emotional
reaction’ scale in previous research.
Results—We found that labels rated high on emotional reaction were better remembered,
associated with reduction in the urge to smoke, and produced greater brain response in the
amygdala, hippocampi, inferior frontal gyri and the insulae.
Conclusions—Recognition memory and craving are, respectively, correlates of effectiveness of
addiction related public health communications and interventions, and amygdala activation
facilitates the encoding of emotional memories. Thus, our results suggest that emotional reaction
to graphic warning labels contributes to their public health impact and may be an integral part of
the neural mechanisms underlying their effectiveness. Given the urgency of the debate about the
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constitutional risks and public health benefits of graphic warning labels, these preliminary findings
warrant consideration while longitudinal clinical studies are underway
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Introduction
Warning labels on cigarette packages have long been considered an important venue for
communicating the health risks of smoking.12 In 2009, the US Congress mandated graphic
warning labels on cigarette packs to contain both textual warnings and color images
depicting the negative health consequences of smoking.3 The law specified the textual
messages and charged the US Food and Drug Administration (FDA) with selecting the
images to accompany them. For this purpose, FDA conducted an online survey of 36
candidate labels and selected nine of them based on survey results.4 However, the
anticipated implementation of the new labels was postponed by the legal action of five US
tobacco companies who argued that the proposed highly emotional graphic labels were
unconstitutional, in part because they ‘were chosen not to convey information, but to evoke
negative emotions and thereby discourage smoking’.5 The US District Court for the District
of Columbia ruled for the plaintiffs, opining that evidence of the graphic labels effectiveness
presented by the FDA was insufficient to justify an encroachment on tobacco companies'
right to free commercial speech.6 In plaintiff 's opinion, the images on the labels exceeded
FDA's mission to inform the consumer. Indeed, eight out of nine labels selected by the FDA
scored highest on a scale of emotional reaction (ER) in an Internet survey of 9474 adult
smokers commissioned by the FDA.34 The survey asked participants to rate their ER to a
cigarette pack they had just viewed online in regard to seven dimensions, such as
‘depressed’, ‘worried’ and ‘disgusted’. The District of Columbia Circuit Court of Appeals
affirmed the District Court ruling.5
This case brought to the fore the fact that despite a growing number of observational and
behavioral studies showing positive effects of warning labels1 and a broad international
support for the inclusion of strong, negatively valenced images on cigarette warning
labels,7–19 the neurobiological mechanisms of their action remain unclear. Determining
whether a strong ER enhances label effectiveness would help settle the debate on whether
their public health benefit outweighs the potential encroachment on the tobacco companies'
First Amendment rights.20
Functional magnetic resonance imaging (fMRI) in conjunction with formal behavioral
paradigms has been used successfully to elucidate the neuroanatomical, cognitive and
emotional mechanisms underlying basic processes, such as memory encoding and retrieval,
applied to persuasive health communications. 2122 Recognition accuracy is commonly used
to evaluate learning and is a surrogate outcome measure of the effectiveness of public health
communications.23–25 Studies show that emotion affects remembering learned material, a
process involving an interaction between the amygdala and hippocampus-based memory
systems.26–28 While a majority of studies suggest that emotion facilitates memory
Wang et al. Page 2
Tob Control. Author manuscript.
formation, the relationship is complex and the subject of active research.29–32 In the present
study, we used fMRI, recognition memory and cigarette craving to compare the functional
neuroanatomical, cognitive and motivational impact of the labels rated high and low on the
ER scale.4 We hypothesized that the greater emotional response evoked by High ER labels
will facilitate the processing of the information they contain, reflected in greater activation
of the amygdala, hippocampus and insula and resulting in better recognition and greater
acute reduction in cigarette craving compared to Low ER labels.
Materials and Methods
Participants
Twenty-four (8 female) non-treatment seeking, right-handed smokers, 28.13±7.84 (mean
±SD) years old, with 14.00±1.87 years of education, were recruited through advertisement
and gave written consent to participate in the study approved by the University of
Pennsylvania Institutional Review Board. Participants smoked 13.85±6.45 cigarettes per day
in the previous 30 days and had Fagerström Test for Nicotine Dependence (FTND) scores33
of 3.63±2.72. Exclusion criteria were (1) Current Diagnostic and Statistical Manual Fourth
Edition Text Revision (DSM-IV-TR) Anxiety, Mood, Cognitive or Psychotic Disorder;34 (2)
medical or neurological disorder or treatment that may affect the cerebrovascular system; (3)
urine drug screen (UDS, Reditest Panel-Dip Drug Screen, Redwood Toxicology Labs, Santa
Rosa, California, USA) positive for illicit opioids, benzodiazepines, cocaine or
methamphetamines; (4) non-detectable urine cotinine by qualitative urinary test (Reditest
Smoke Cassette, Redwood Toxicology Labs, Santa Rosa, California, USA); (5) currently
receiving treatment for addiction of any kind; (6) currently using nicotine-containing
products or treatments other than cigarettes (eg, nicotine patch, smokeless tobacco); (7)
currently seeking or planning to seek treatment for smoking cessation in the next 2 months;
and (8) medical contraindications for MRI scanning.
Stimuli
From the 36 warning labels that were previously evaluated by adult smokers in an FDA-
commissioned Internet survey,4 we selected the 12 labels that were rated the highest and the
12 labels that were rated the lowest on the ER scale (1=Not at all, 5=completely). High ER
labels (18.55±0.55, range 17.8–19.4) differed significantly from Low ER labels
(15.48±0.83, range 14–16.5; independent sample t test, p<0.001). In addition, we created
‘scrambled’ images to be used as controls, by dividing graphic warning labels into 1 cm2
and rearranging them randomly within each label.35 We compared participants' responses to
12 of these control images to responses to High ER and Low ER labels. Figure 1 shows an
example from the three stimuli categories.
Tasks—Graphic labels fMRI task: The labels were presented in a block design paradigm36
with six different blocks for each of three stimulus types: HIGH (ie, High ER graphic
warning labels), LOW (ie, Low ER graphic warning labels) and CONTROL (ie, scrambled
graphic warning labels). Each block contained a sequence of six images, randomly selected
from the appropriate set of 12 (HIGH, LOW or CONTROL), and each image appeared for
two seconds. Throughout the fMRI task, each image was presented three times. Before and
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after each block, participants were prompted to answer the question “How much do you
want to smoke a cigarette right now?” They used a single axis scroll wheel (FORP; Current
Designs Inc, Philadelphia) to indicate their ratings on a visual analogue scale (VAS) with a
range from ‘not at all’ (left=0) to ‘extremely’ (right=10). The inter-block-intervals were
between 10 and 13 s long, with a white crosshair shown in the middle of the screen against a
black background. Participants were instructed to attend to each image presented. All stimuli
were delivered using the Presentation stimulus presentation package (Neurobehavioral
System Inc, Albany, California, USA) and presented through a rear projector system (Epson
America) that was viewed through a mirror mounted on the MRI scanner head coil. The
duration of the graphic labels fMRI task was 9.3 min.
Recognition task: This task assessed memorability of the graphic warning labels 20 min
after completion of the graphic labels fMRI task. Participants completed the task outside the
scanner, using a Lenovo ThinkPad T420s laptop with a 14” HD display running MediaLab
software (MediaLab Inc, Georgia, USA). This was modeled after a previously reported
paradigm used to test the memorability of smoking-cessation ads.23–25 The task contained a
total of 48 labels: 24 targets (12 High ER and 12 Low ER warning labels) that participants
were shown in the fMRI task, and 24 comparable warning labels that were not shown (foils).
Participants were asked to respond with a ‘Yes’ or ‘No’ to the question ‘Have you seen this
label in the scanner?’ displayed on top of each image.
Procedure
Participants were assessed for eligibility for MRI, demographics, the average number of
cigarettes smoked per day in the preceding week, FTND and handedness.37 On their arrival,
participants provided urine samples for the urine drug screen and cotinine levels to confirm
their smoking status. Between 30 and 45 min before the MRI session, participants were
escorted outdoors to smoke one of their own cigarettes under observation, so as to be in a
uniformly non-deprived state. All participants took the opportunity to smoke and consumed
no more than one cigarette. Participants performed the graphic labels fMRI task in the
scanner. The recognition task was administered outside of the scanner approximately 20 min
after the end of the graphic labels fMRI task.
MRI was performed on a whole-body 3 T Siemens Tim Trio scanner (Erlangen, Germany)
using a 32-channel head coil. Blood oxygenation level-dependent (BOLD) fMRI was
performed with a whole-brain, single-shot gradient-echo echoplanar sequence with the
following parameters: repetition time/echo time (TR/TE) =3000/32 ms, Field of view
(FOV)=192Å～192 mm, matrix 64Å～64, slice thickness/gap=3.0/0 mm, 46 slices, yielding
(3 mm)3 voxels.3839 Before BOLD fMRI, a 5 min Magnetization Prepared Rapid Gradient
Echo (MP-RAGE) T1-weighted image (TR/TE=1810/3.51 ms, FOV=250Å～250 mm,
matrix=192Å～256, yielding 0.94Å～0.94Å～1 mm voxels) was acquired for anatomic
overlays of functional data and spatial normalisation.40 (please see the Glossary of
Technical Terms in the online supplementary file for an explanation of neuroimaging
acronyms and technical terms).
Wang et al. Page 4
Tob Control. Author manuscript.
Behavioral data analysis
Changes in self-reported craving ratings were calculated as
Craving_change=After_exposure—Before_exposure for each block, averaged according to
the type of stimulus block, thus generating three Craving_change scores:
Craving_change_HighER, Craving_change_LowER and Craving_change_Control. A one
way repeated-measures ANOVA was applied on Craving_change scores to examine the
effect of label exposure on cigarette craving. Performance on the recognition task was
calculated as per cent correct recognition: thus the score for either High or Low ER labels
was 100Å～(correct responses)/12. Since we were interested in how well participants could
recognize the labels shown in the graphic labels fMRI task, instead of how well they could
reject ones not shown, we did not include responses to foils in the calculation. A paired-
sample t test was applied to examine if there was a difference in recognition accuracy
between High and Low ER warning labels.
Imaging data analysis
Whole brain voxel-wise analysis: BOLD time series data were preprocessed and analyzed
by standard procedures using the fMRI Expert Analysis Tool (FEAT V.5.98) of FSL
(FMRIB's Software Library). Single-participant preprocessing included removal of regions
outside the brain using brain extraction tool,41 slice time correction, motion correction to the
median image using the Motion Correction version of FMRIB's line image registration tool
(MCFLIRT),42 high-pass temporal filtering with a cut-off of 50s, spatial smoothing using a
Gaussian kernel (5 mm full-width at half-maximum, isotropic) and mean based intensity
normalization of all volumes using the same multiplicative factor. The median functional
volume was co-registered to the anatomical T1-weighted structural volume, which was then
registered to the standard anatomical space (Montreal Neurological Institute (MNI) T1
template). Statistical contrast maps were then transformed into standard space using one call
to FMRIB's FLIRT4243 per participant (ie, combine the two transformation matrices into a
single matrix, and then apply that matrix to go directly from functional space to MNI space
in one transformation).
Participant-level statistical analyses were performed voxel-wise using FILM (FMRIB's
Improved General Linear Model) with local autocorrelation correction.44 Three condition
events (ie, HIGH, LOW and CONTROL) were modeled using a double-γ haemodynamic
response function. At the group-level analysis, participant-level contrast maps were entered
into single group t tests to identify brain activation for conditions and contrasts of interest.
Group z (Gaussianised T) statistic images were generated for the following pairs: (1)
LABEL>CONTROL; (2) HIGH>LOW. Group maps were thresholded at the voxel level of
z=2.3 and cluster corrected at p<0.05 using family-wise error rate correction based on
Gaussian Random Field theory.45 Anatomic assignment of clusters was based on the peak z-
score within the cluster using the Talairach Daemon Database confirmed by visual
inspection.40 Whole brain correlation analysis: To examine the relationship between brain
response to graphic warning labels and smoking addiction severity, as well as the
performance on the recognition task, whole brain correlation analyses were conducted. The
FTND score and per cent correct recognition for each participant were entered as covariates
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of interest for the LABEL> CONTROL contrast separately. The resulting positive and
negative correlation maps were corrected as described above.
Results
Behavior
One-way repeated ANOVA revealed an overall effect of graphic warning labels on self-
reported change in cigarette craving (F(19,2)=10.18, p<0.001). Post hoc tests indicated that
although exposure to both High and Low ER labels reduced self-reported craving when
compared to control images (High p=0.001; Low p=0.018), the effect of High ER labels was
greater than that of Low ER labels (p=0.020). Moreover, the High ER labels were better
recalled than the Low ER labels (High ER 92.80±0.02%; Low ER 80.68±0.03%, paired
samples t test t=4.538, p<0.001).
Imaging
Five participants' imaging data were excluded for excessive movement in the scanner (>3
mm in any direction), leaving 19 data sets for the final analysis. Compared to control
images, graphic warning labels evoked greater activation in the bilateral occipitoparietal
cortex, including visual and fusiform areas, cuneus and precuneus, bilateral temporal and
inferior frontal cortices, as well as the amygdala, hippocampus and parahippocampus (Table
1). Compared to Low ER labels, High ER labels were associated with greater response in the
right fusiform (occipital part) gyrus, inferior frontal gyrus, thalamus, anterior insula,
amygdala and hippocampus, as well as the cerebellum (Figure 2 and Table 2). Whole-brain
correlation revealed that brain activation in the precuneus and the medial frontal cortex was
positively correlated with performance on the recognition task (z=2.3, p<0.05; table 3 and
figure 3). Brain activation in the precuneus was negatively correlated with smoking
addiction severity as measured by FTND (z=2.3, p<0.05; Table 4).
Discussion
We found that the graphic warning labels associated with stronger emotional reaction (ER)
had greater effects and differed from those associated with less ER on two key indicators of
effectiveness: recognition memory and reduction in the immediate urge to smoke. The
neuroimaging findings were congruent with recognition memory performance: High ER
labels evoked greater neural activation in brain regions mediating emotional memory, such
as the amygdala, hippocampi, inferior frontal gyri and insulae, than the Low ER labels.
Multiple lines of evidence indicate that amygdala activation during stimulus processing
modulates the encoding and consolidation of memory,2746 as well as its retrieval.47
Neuroimaging studies show that activation of the amygdala, hippocampus and prefrontal
regions during the encoding of emotional stimuli is positively correlated with delayed
recognition accuracy for aversive and emotionally arousing but not neutral videos and
pictures. 48–50 The amygdala mediates emotional learning and facilitates memory formation
in the hippocampus and prefrontal cortex.465152 In line with previous studies, our brain and
behavioral findings suggest that the emotional salience of graphic labels might play an
important role in enhancing their impact by engaging brain regions mediating learning and
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memory. Therefore, High ER warnings may owe their superior recognition to their greater
emotional salience.
We also found increased anterior insula and inferior prefrontal cortex activation associated
with processing of the High ER labels. The insula has traditionally considered the hub of a
network that includes amygdala and prefrontal cortex responsible for conversion of sensory
information into feelings, such as aversion.53 More recently, insula involvement in addiction
has been narrowed down to the recall of interoceptive drug effects when drug taking is
perceived as risky or where there is a conflict between the drug taking and more adaptive
goals.54 Thus, greater activation of the anterior insula and inferior frontal gyrus associated
with viewing the High ER labels is consistent with these labels conveying greater perception
of the hazards of smoking. Finally, greater activation of the fusiform cortex associated with
processing of the High ER labels is consistent with its role in the earlier stages of processing
of emotional visual stimuli.55
These findings suggest that emotional imagery in graphic warning labels is an integral factor
in the labels' memorability. The superior short-term memory for High ER labels suggests
that stronger ERs facilitate more accurate transmission of knowledge about the risks of
smoking, which is an important public health objective in its own right, as well as an
important step toward a prospective evaluation of the long-term clinical outcomes of graphic
warning labels. In addition, we found that greater activation of the precuneus and frontal
gyri during the processing of the warning labels predicted better recognition. Both the
precuneus and medial frontal cortex are involved in ‘self-referential’ processing.56 Prior
neuroimaging studies showed that increased response to personally relevant smoking
cessation messages in these brain areas predicted better outcomes (quitting) during a 4-
month follow-up.2157 Thus, precuneus and medial frontal activation may indicate greater
self-referential processing that facilitates remembering of the labels. If replicated, this
finding may have potential application in the design of graphic warning labels. Nevertheless,
the negative relationship we found between smoking addiction severity, as measured by
FTND, and the precuneus response suggests that addiction severity may impair smokers'
ability to relate to the warnings.1558–60
Our study included predominantly loss-framed labels and excluded non-daily smokers and
non-smokers. The latter include important populations, such as youth at risk of becoming
addicted smokers.61 In population-level studies, loss-framed labels, that is, carrying images
and text emphasizing the negative health consequence of smoking, have been generally
found to be more effective than gain-framed labels.1862–64 However, since processing in
‘uninvolved’ (eg, not addicted) audiences may differ from ‘involved’ (ie, addicted) smokers,
further studies evaluating gain and loss-framed labels in potential smokers would be
required to extend our findings to this important target audience.186265–68 Finally, although
better recognition and greater reduction in craving suggest greater efficacy of the High ER
labels in reducing smoking, longitudinal studies are required to determine whether our
findings translate to clinical outcomes, expressed by quantitative biomarkers, such as
nicotine metabolite levels.
Wang et al. Page 7
Tob Control. Author manuscript.
Taken together, our findings provide the first neuroimaging data showing that graphic
warning labels that evoke greater ER also produce greater activation of the brain regions
mediating emotional memory, and are associated with better label recognition and greater
reduction in the urge to smoke. These results suggest that the ER elicited by graphic labels
contributes to their behavioral impact. Controlled longitudinal studies are required to
determine whether our findings are maintained over time and translate from the cognitive,
motivational and neurophysiological correlates of effectiveness to the clinical outcomes. In
addition to directly contributing to the current regulatory and legal debate about the
implementation of graphic warning labels in the USA, the study provides a blueprint for
future applications of neuroimaging to evaluate the labeling and packaging of tobacco
products.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What this paper adds
What is already known on this subject
• Despite broad consensus about the benefits of using strong, negatively valenced
images in cigarette warning labels, their neurobehavioral mechanisms of action
and effectiveness in changing behaviour remained unclear.
• Existing data are largely derived from cross-sectional studies that relied on self
reported measures. Neuroimaging is more sensitive to the neurophysiological
mechanisms underlying effectiveness, than self-report.
What important gaps in knowledge exist on this topic
• The question of whether emotional salience is essential to graphic warning label
effectiveness has been at the core of the legal and public debate on whether the
labels' public health benefit outweighs the potential encroachment on the
tobacco companies' First Amendment rights. Evidence of graphic labels'
neurophysiological impact measured by objective neuroimaging probes such as
functional MRI could help settle this debate.
What this study adds
• This study provides the first functional MRI data showing that graphic warning
labels that evoke stronger emotional reaction produce greater activation of the
brain regions mediating emotional memory, and are associated with better
recognition and greater reduction in the urge to smoke, suggesting that stronger
emotional arousal elicited by graphic labels is important for their behavioural
impact.
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Figure 1.
Examples of stimuli used in the graphic labels functional MRI (fMRI) task.
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Figure 2.
Greater brain activation associated with processing of High emotional reaction (ER)
compared to Low ER warnings. Statistical map (red-yellow scale) is displayed over a
standard Montreal Neurological Institute space T1-weighted average structural template
image and thresholded at z=2.3 (cluster corrected for multiple comparison at p<0.05).
Greater brain activation associated with processing of High ER compared to Low ER
warnings. Statistical map (red yellow scale) is displayed over a standard MNI space T1-
weighted average structural template image and thresholded at z = 2.3 (cluster corrected for
multiple comparison at p<0.05).
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Figure 3.
Whole-brain correlation between brain response to graphic warning labels (High+Low
emotional reaction (ER) together, compared to Control images) and performance in the
recognition task (overall correct recognition scores). Significant positive correlations are
present in the precuneus and medial frontal cortex (MFC) (z=2.3, cluster corrected for
multiple comparisons at p<0.05; Table 3). There were no significant negative correlations at
this threshold.
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